Dopal
Dopal is a metabolite and aldehyde neurotoxin of Dopamine (HY-B0451). Dopal exhibits cytotoxicity, induces α-synuclein oligomerization and aggregation, and is closely associated with the pathogenesis of Parkinson's disease. Dopal can be used in research related to Parkinson's disease.
For research use only. We do not sell to patients.
- Purity : 90.0%
- CAS No.: 5707-55-1
- Formula: C8H8O3
- Molecular Weight:152.15
-
Storage:
-80°C
All α-synuclein Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
α-synuclein Aggregation |
In Vitro
Dopal (1.5-1500 μM; 0-4 h) induces dose- and time-dependent aggregation of purified human recombinant α-synuclein in a cell-free system; aggregation initiates at concentrations as low as 1.5 μM, and large polymeric α-synuclein aggregates form at concentrations of 300 μM and above[1].
Dopal (3 μM-1 mM; 2-8 h) induces dose-dependent α-synuclein aggregation and cytotoxicity in SHSY-5Y cells overexpressing wild-type α-synuclein, with significant aggregation observed at concentrations ≥30 μM, oligomer formation initiated at 3 μM, and rapid cell death occurring at 1 mM[1].
Dopal (100-150 μM; 18-24 h) exhibits toxicity to SH-SY5Y cells and also induces cell apoptosis[2].
Dopal (100-200 μM; 16-24 h) induces the formation of α-synuclein-EGFP dimers in SH-SY5Y cells overexpressing α-synuclein-EGFP[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:SH-SY5Y neuroblastoma cells
-
Concentration:100 μM
-
Incubation Time:24 h
-
Result:Induced ~30% death in the SH-SY5Y cell population, significantly reducing cell viability compared to untreated controls.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (male, 2-month-old, 300 g, unilateral stereotactic injection into substantia nigra)[1]
-
Dosage:1.0 μg; 0.2 μg
-
Administration:stereotactic injection into substantia nigra; single dose
-
Result:Increased 50 to 170 kDa α-synuclein (AS) oligomers by 2.75-fold relative to vehicle control, with these oligomers accounting for 63% of total AS at 4 hours post-injection with 1.0 μg dose.
Induced a lesser increase in 50 to 170 kDa AS oligomers at 4 hours post-injection with 0.2 μg dose compared to 1.0 μg dose.
Caused loss of tyrosine hydroxylase immunoreactivity in the substantia nigra at 24 and 48 hours post-injection with both 1.0 μg and 0.2 μg doses. Failed to detect large AS aggregates via immunohistochemistry at 4, 24, or 48 hours post-injection.
Chemical Information
-
CAS No. 5707-55-1
-
Appearance Liquid
-
Molecular Weight 152.15
-
Formula C8H8O3
-
Color Colorless to light yellow
-
SMILES
O=CCC1=CC=C(O)C(O)=C1
-
Shipping
Shipping with dry ice.
-
Storage
-80°C
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Human pluripotent stem cell midbrain dopaminergic neuron differentiation
Human pluripotent stem cells are directed toward midbrain dopaminergic neurons by first inducing a neural floor-plate-like progenitor state, then patterning cells with ventralizing SHH signaling and midbrain/WNT-FGF cues, and finally maturing progenitors into neurons expressing dopaminergic markers such as TH, NURR1/NR4A2, PITX3, DAT/SLC6A3, VMAT2/SLC18A2, GIRK2/KCNJ6, FOXA2, LMX1A, and EN1. The main readouts are loss of pluripotency, acquisition of FOXA2+/LMX1A+ midbrain floor-plate progenitors, emergence of βIII-tubulin+/MAP2+ neurons, and production of TH+ dopaminergic neurons with molecular, dopamine-release, and electrophysiological features of midbrain dopaminergic identity.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Burke WJ, et al. Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. Acta Neuropathol. 2008;115(2):193-203. [Content Brief]
[2]. Bloch DN, et al. Scavenging neurotoxic aldehydes using lysine carbon dots. Nanoscale Adv. 2023;5(5):1356-1367. Published 2023 Jan 19. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)